Overview
Amgen is a biotechnology company in Thousand Oaks, California, that discovers, develops, manufactures and markets human therapeutics; Forbes records its founding on 8 April 1980.[2] Its Forbes sales of US$37.3bn rose 12.2% on the prior-year figure, and profit was US$7.8bn with a market value of US$176.1bn.[2] Amgen is the largest company in the ranking that describes itself as a biotechnology company rather than a pharmaceutical company. It keeps fourteenth place. The company employs 31,500 people, under a quarter of Johnson & Johnson’s workforce.[2]
Amgen strengths and limitations
Strengths
- Largest self-described biotechnology company in the list
- Sales growth of 12.2%
- Profit margin above 20%
Limitations
- Smaller than the European majors
- Workforce and sales far below the top ten
- Several mature products face biosimilar competition
Appears in
Amgen peers and competitors
Companies ranked in the same lists as Amgen.
Johnson & Johnson
Takeda Pharmaceutical
Daiichi Sankyo- Astellas Pharma
Viatris- Regeneron Pharmaceuticals
- CSL
Otsuka Holdings- Teva Pharmaceutical
Merck KGaA
Gilead Sciences
GSK plc
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.